SCHEMBL6804476

SCHEMBL6804476

O=C(O)c1ccccc1-c1ccc(N2CCOCC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.52
LMNA P02545 1/20 0.51
ALDH1A1 P00352 5/20 0.51
MAPT P10636 4/20 0.51
KDM4E B2RXH2 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
TDP1 Q9NUW8 2/20 0.51
HPGD P15428 1/20 0.51
MAPK1 P28482 1/20 0.51
CFTR P13569 2/20 0.50
PIK3CD O00329 1/20 0.50
PIK3CA P42336 1/20 0.50
PIK3CB P42338 1/20 0.50
PIK3CG P48736 1/20 0.50
PRKDC P78527 1/20 0.50
HSD17B10 Q99714 1/20 0.50
POLB P06746 1/20 0.50
DNMT1 P26358 1/20 0.50
APEX1 P27695 1/20 0.50
RECQL P46063 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2565236 0.87 BCAT2 (0.56) CNR2LMNAALDH1A1MAPTKDM4E
SCHEMBL6803972 0.86 DHODH (0.60) LMNAALDH1A1MAPTL3MBTL1TDP1
SCHEMBL6638818 0.85 KMO (0.55) LMNAALDH1A1MAPTKDM4EL3MBTL1
SCHEMBL6637186 0.84 ALDH1A1 (0.47) LMNAALDH1A1MAPTL3MBTL1HPGD
SCHEMBL25206256 0.80 CNR2 (0.45) CNR2ALDH1A1MAPTKDM4EL3MBTL1
SCHEMBL15560003 0.79 KMT2A (0.68) LMNAALDH1A1MAPTKDM4EL3MBTL1
SCHEMBL10690677 0.79 PRKDC (0.64) LMNAALDH1A1MAPTKDM4EL3MBTL1
SCHEMBL30292805 0.78 HNF4A (0.63) ALDH1A1KDM4EHPGDHSD17B10CYP2C9
SCHEMBL18759613 0.78 HNF4A (0.63) ALDH1A1KDM4EHPGDHSD17B10CYP2C9
SCHEMBL28090800 0.77 BCAT2 (0.64) LMNAALDH1A1MAPK1POLBRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157866-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157866-A1 Amide compounds APOB, NR1H2, NR1H3 CNR2 49/4885LMNA 956/4885ALDH1A1 2901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.